Medium materiality6/10
UBS raises BrightSpring Health target to $92
Why it may matterVerify against the original reporting
The target suggests meaningful upside, tempered by the uncertainty inherent in analyst estimates.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raised its BTSG price target to $92 versus a posted price of $66.89, a substantial bullish target gap.
- Target: $92 versus posted price: $66.89
- Target implies roughly 38% upside from the posted price
Key facts
- 01
Target: $92
- 02
Posted price: $66.89
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.